• Altimmune, Inc. (NASDAQ:ALT) Receives Average Rating of "Buy" from Analysts

    Источник: Buzz FX / 26 фев 2025 02:26:19   America/New_York


    Altimmune, Inc. (NASDAQ:ALT) Receives Average Rating of "Buy" from Analysts Written by MarketBeat February 26, 2025 Share Link copied to clipboard. Altimmune, Inc. ( NASDAQ:ALT - Get Free Report ) has been given an average recommendation of
    Read more...
Опубликовать